Pharmacogenetics education in British medical schoolsReport as inadecuate




Pharmacogenetics education in British medical schools - Download this document for free, or read online. Document in PDF available to download.

Genomic Medicine

, Volume 2, Issue 3–4, pp 101–105

First Online: 12 April 2009Received: 14 February 2009Revised: 21 March 2009Accepted: 26 March 2009DOI: 10.1007-s11568-009-9032-6

Cite this article as: Higgs, J.E., Andrews, J., Gurwitz, D. et al. HUGO J 2008 2: 101. doi:10.1007-s11568-009-9032-6

Abstract

Pharmacogenetic tests allow medications to be tailored to individual patients to improve efficacy and reduce drug toxicity. In 2005, the International Society of Pharmacogenomics ISP made recommendations for undergraduate medical teaching in pharmacogenetics. We aimed to establish the quantity and scope of this in British medical schools. An electronic survey was sent to all British medical schools. Nineteen out of 34 56% medical schools responded. Sixteen of the 19 84% respondents provided pharmacogenetics teaching, usually 1–2 h in total. Only four 21% medical schools offered the four or more hours of teaching recommended by the ISP. However, 10 of 16 63% schools felt the amount of pharmacogenetic teaching offered was sufficient. The quantity of undergraduate teaching of pharmacogenetics is low. However, a majority of UK medical schools teach it, covering a broad scope of elements. It is encouraging that future clinicians are being provided with the knowledge to deliver pharmacogenetics into clinical practice.

KeywordsPharmacogenetics Pharmacogenomics Teaching Education Medical schools Survey Electronic supplementary materialThe online version of this article doi:10.1007-s11568-009-9032-6 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Jenny E. Higgs - Julie Andrews - David Gurwitz - Katherine Payne - William Newman

Source: https://link.springer.com/







Related documents